• Home
  • Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: history and rationale.

Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: history and rationale.

Author List
Ryan CJ, Lin AM, Small EJ
Publication
Urologic oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1448233
Publication Year
2006
PubMed ID
16678059
Publication Title
Ryan CJ, Lin AM, Small EJ. Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: history and rationale. Urol Oncol. 2006 May-Jun; 24(3):250-3.